RNA | MedPath Search

Clinical Trials

Find the latest clinical trials by condition, location & phase

Browse and search for drug monographs and related information

Approved pharmaceutical products by global regulatory authorities

Explore a comprehensive list of organizations, including their profiles and details

Latest updates on clinical trials, pharmaceuticals, and healthcare companies

|

Filters

Study Phase

Early Phase 1

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

Phase 4

Not Applicable

Recruitment Status

Recruiting

Not yet recruiting

Active, not recruiting

Completed

Suspended

Terminated

Withdrawn

Study Type

Interventional

Observational

Expanded Access

Others

Eligibility Sex

All

Female

Male

Healthy Volunteers

All

Include

Exclude

Found 452 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "RNA"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration

Phase 2

Completed

Conditions: Macular Degeneration

Interventions: Drug: Bevasiranib

First Posted Date: 2005-12-01

Last Posted Date: 2008-08-05

Lead Sponsor: OPKO Health, Inc.

Target Recruit Count: 120

Registration Number: NCT00259753

Locations: 🇺🇸
Associated Retinal Consultants, P.C., Royal Oak, Michigan, United States
🇺🇸
Retina-Vitreous Consultants, Livingston, New Jersey, United States
🇺🇸
Vitreoretinal Consultants Houston TX, Houston, Texas, United States

and more 20 locations

Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients

Phase 1

Completed

Conditions: Melanoma Stage III or IV

Interventions: Biological: autologous dendritic cell vaccine

First Posted Date: 2005-10-24

Last Posted Date: 2009-09-29

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 64

Registration Number: NCT00243529

Locations: 🇳🇱
Radboud University Nijmegen Medical Center, Nijmegen, PO Box 9101, Netherlands

Comparison of Fecal Ribonucleic Acid (RNA) Test With Fecal Occult Blood Test (FOBT) for Detecting Colorectal Cancer and Adenoma

Conditions: Colorectal Cancer

First Posted Date: 2005-09-20

Last Posted Date: 2009-08-04

Lead Sponsor: Hamamatsu University

Target Recruit Count: 400

Registration Number: NCT00197405

Locations: 🇯🇵
Hamamatsu University School of Medicine, Hamamatsu, Japan

Tumor RNA Transfected Dendritic Cell Vaccines

Phase 1

Completed

Conditions: Prostate Cancer

First Posted Date: 2005-04-15

Last Posted Date: 2009-01-21

Lead Sponsor: US Department of Veterans Affairs

Registration Number: NCT00108264

Locations: 🇺🇸
Durham VA Medical Center, Durham, North Carolina, United States

RNA-Loaded Dendritic Cell Cancer Vaccine

Phase 1

Completed

Conditions: Renal Cell Carcinoma

Interventions: Biological: MB-002

First Posted Date: 2004-07-20

Last Posted Date: 2013-02-18

Lead Sponsor: Argos Therapeutics

Target Recruit Count: 26

Registration Number: NCT00087984

Locations: 🇺🇸
University of California - Irvine, Orange, California, United States
🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada

and more 2 locations

Biological Therapy in Treating Patients With Metastatic Cancer

Phase 1

Completed

Conditions: Breast Cancer
Colorectal Cancer
Extrahepatic Bile Duct Cancer
Gallbladder Cancer
Gastric Cancer
Head and Neck Cancer
Liver Cancer
Lung Cancer
Metastatic Cancer
Ovarian Cancer

Interventions: Biological: CEA RNA-pulsed DC cancer vaccine

First Posted Date: 2004-04-28

Last Posted Date: 2013-02-22

Lead Sponsor: Duke University

Target Recruit Count: 24

Registration Number: NCT00004604

Locations: 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States

Immunotherapy in Treating Patients With Metastatic Breast Cancer

Phase 1

Terminated

Conditions: Breast Cancer

Interventions: Biological: carcinoembryonic antigen RNA-pulsed DC cancer vaccine

First Posted Date: 2003-04-25

Last Posted Date: 2013-11-06

Lead Sponsor: Duke University

Target Recruit Count: 4

Registration Number: NCT00003432

Locations: 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States

A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 399

Registration Number: NCT00000916

Locations: 🇺🇸
Harbor-UCLA Med. Ctr. CRS, Torrance, California, United States
🇺🇸
Weiss Memorial Hosp., Chicago, Illinois, United States
🇺🇸
Massachusetts General Hospital ACTG CRS, Boston, Massachusetts, United States

and more 31 locations

A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNA

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 70

Registration Number: NCT00000840

Locations: 🇺🇸
Northwestern Univ Med School, Chicago, Illinois, United States
🇺🇸
Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States
🇺🇸
Ohio State Univ Hosp Clinic, Columbus, Ohio, United States

and more 5 locations

The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients

Phase 4

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Merck Sharp & Dohme LLC

Target Recruit Count: 540

Registration Number: NCT00002376

Locations: 🇺🇸
Kaiser Foundation Hospital, San Francisco, California, United States

Prev
1
42
43
44
45
46
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy